NYSE:GRA - W. R. Grace & Co Stock Price, Forecast & News

W. R. Grace & Co trades on the New York Stock Exchange (NYSE) under the ticker symbol "GRA."

W. R. Grace & Co declared a quarterly dividend on Thursday, October 24th. Stockholders of record on Thursday, November 14th will be paid a dividend of $0.27 per share on Thursday, December 5th. This represents a $1.08 annualized dividend and a dividend yield of 1.56%. The ex-dividend date is Wednesday, November 13th. View W. R. Grace & Co's Dividend History.

W. R. Grace & Co (NYSE:GRA) issued its quarterly earnings results on Thursday, October, 24th. The specialty chemicals company reported $0.98 EPS for the quarter, topping the consensus estimate of $0.91 by $0.07. The specialty chemicals company had revenue of $470.50 million for the quarter, compared to the consensus estimate of $487.44 million. W. R. Grace & Co had a net margin of 11.34% and a return on equity of 73.68%. The company's revenue for the quarter was down 4.9% compared to the same quarter last year. During the same quarter last year, the firm posted $1.11 EPS. View W. R. Grace & Co's Earnings History.

W. R. Grace & Co is scheduled to release their next quarterly earnings announcement on Tuesday, February 4th 2020. View Earnings Estimates for W. R. Grace & Co.

W. R. Grace & Co will be holding an earnings conference call on Tuesday, February 4th at 12:00 AM Eastern. Interested parties can register for or listen to the call using this link or dial in at Not Available.

9 analysts have issued 12-month price objectives for W. R. Grace & Co's stock. Their forecasts range from $72.00 to $95.00. On average, they anticipate W. R. Grace & Co's stock price to reach $84.22 in the next twelve months. This suggests a possible upside of 21.5% from the stock's current price. View Analyst Price Targets for W. R. Grace & Co.

9 Wall Street analysts have issued "buy," "hold," and "sell" ratings for W. R. Grace & Co in the last year. There are currently 1 hold rating and 8 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for W. R. Grace & Co.

Press coverage about GRA stock has been trending somewhat negative recently, according to InfoTrie. The research firm ranks the sentiment of news coverage by monitoring more than six thousand news and blog sources in real-time. The firm ranks coverage of companies on a scale of negative five to positive five, with scores closest to five being the most favorable. W. R. Grace & Co earned a news sentiment score of -1.9 on InfoTrie's scale. They also assigned media coverage about the specialty chemicals company a news buzz of 10.0 out of 10, indicating that recent news coverage is extremely likely to have an impact on the company's share price in the near term. View News Stories for W. R. Grace & Co.

W. R. Grace & Co saw a increase in short interest in the month of December. As of December 31st, there was short interest totalling 803,700 shares, an increase of 23.2% from the December 15th total of 652,300 shares. Based on an average daily volume of 364,800 shares, the short-interest ratio is currently 2.2 days. Approximately 1.3% of the company's shares are short sold. View W. R. Grace & Co's Current Options Chain.

Some companies that are related to W. R. Grace & Co include Ecolab (ECL), Sherwin-Williams (SHW), International Flavors & Fragrances (IFF), Celanese (CE), RPM International (RPM), Albemarle (ALB), NewMarket (NEU), Ashland Global (ASH), Balchem (BCPC), Quaker Chemical (KWR), PolyOne (POL), Sensient Technologies (SXT), Innospec (IOSP), HB Fuller (FUL) and Stepan (SCL).

Based on aggregate information from My MarketBeat watchlists, some companies that other W. R. Grace & Co investors own include Under Armour (UAA), Verizon Communications (VZ), Wells Fargo & Co (WFC), Intel (INTC), Energy Transfer LP Unit (ET), General Electric (GE), Advanced Micro Devices (AMD), First Solar (FSLR), Vertex Pharmaceuticals (VRTX) and Walgreens Boots Alliance (WBA).

W. R. Grace & Co's stock is owned by a number of of retail and institutional investors. Top institutional shareholders include Tocqueville Asset Management L.P. (0.53%), Private Trust Co. NA (0.02%) and Cerebellum GP LLC (0.01%). Company insiders that own W. R. Grace & Co stock include Alfred E Festa, Elizabeth C Brown, Force Andrew Hudson La III, Mark A Shelnitz, North Latitude Fund Lp 40, North Latitude Master Fund 40, Thomas E Blaser and William C Dockman. View Institutional Ownership Trends for W. R. Grace & Co.

GRA stock was sold by a variety of institutional investors in the last quarter, including Private Trust Co. NA. Company insiders that have sold W. R. Grace & Co company stock in the last year include Mark A Shelnitz and William C Dockman. View Insider Buying and Selling for W. R. Grace & Co.

GRA stock was acquired by a variety of institutional investors in the last quarter, including Tocqueville Asset Management L.P. and Cerebellum GP LLC. Company insiders that have bought W. R. Grace & Co stock in the last two years include Alfred E Festa, Elizabeth C Brown, Force Andrew Hudson La III, North Latitude Fund Lp 40, North Latitude Master Fund 40, Thomas E Blaser and William C Dockman. View Insider Buying and Selling for W. R. Grace & Co.

Shares of GRA can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

One share of GRA stock can currently be purchased for approximately $69.33.

W. R. Grace & Co has a market capitalization of $4.63 billion and generates $1.93 billion in revenue each year. The specialty chemicals company earns $167.60 million in net income (profit) each year or $4.14 on an earnings per share basis. W. R. Grace & Co employs 3,900 workers across the globe.View Additional Information About W. R. Grace & Co.

The official website for W. R. Grace & Co is http://www.grace.com/.

W. R. Grace & Co's mailing address is 7500 GRACE DRIVE, COLUMBIA MD, 21044. The specialty chemicals company can be reached via phone at 410-531-4000 or via email at [email protected]